What is the current Price Target for the Cortexyme, Inc. stock?

The average Cortexyme, Inc. target price is $8.00. This is 700.00% higher than the current stock price. The highest price target is 1,000.00%, the lowest is 300.00%. 5 Analysts have issued a price target Cortexyme, Inc. 2026 .

How high will the Cortexyme, Inc. stock rise?

No reliable answer can be given as to how high the Cortexyme, Inc. stock will rise. The performance of stocks, including the Cortexyme, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Cortexyme, Inc. stock today?

The performance of Cortexyme, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Cortexyme, Inc. stock fall?

The decline in Cortexyme, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Cortexyme, Inc. Forecast, price target & analysts

$0.99

1.79% yesterday

Nasdaq, Apr 11, 09:46 pm CET

ISIN

US22053A1079

Symbol

QNCX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Cortexyme, Inc. Target price 2025 - Analyst rating & recommendation

Cortexyme, Inc. Classifications & Recommendation:

Buy

100%

Cortexyme, Inc. Price Target

Target Price	$8.00
Price	$1.00
Potential	700.00% register free of charge
Number of Estimates	5

	5 Analysts have issued a price target Cortexyme, Inc. 2026 . The average Cortexyme, Inc. target price is $8.00. This is 700.00% register free of charge higher than the current stock price. The highest price target is $11.00 1,000.00% register free of charge , the lowest is $4.00 300.00% register free of charge .
	A rating was issued by 5 analysts: 5 Analysts recommend Cortexyme, Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Cortexyme, Inc. stock has an average upside potential 2026 of 700.00% register free of charge . Most analysts recommend the Cortexyme, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.31	-0.75
	55.95%	42.75%
P/E		negative

3 Analysts have issued a Cortexyme, Inc. forecast for earnings per share. The average Cortexyme, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.31	55.95%
2025	$-0.75 42.75% Unlock
2026	$-0.69 8.00% Unlock
2027	$-0.59 14.49% Unlock
2028	$-0.25 57.63% Unlock
2029	$0.28 212.00% Unlock

Current	-0.76	37.70%
2025	-1.33 75.00% Unlock
2026	-1.46 9.77% Unlock
2027	-1.69 15.75% Unlock
2028	-4.05 139.64% Unlock
2029	3.61 189.14% Unlock

Cortexyme, Inc....

Current Cortexyme, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
D. Boral Capital	Locked ➜ Locked	Locked	Mar 25 2025
Oppenheimer	Locked ➜ Locked	Locked	Mar 24 2025
D. Boral Capital	Locked ➜ Locked	Locked	Feb 05 2025
D. Boral Capital	Locked ➜ Locked	Locked	Jan 02 2025
Brookline Capital	Locked ➜ Locked	Locked	Dec 18 2024
D. Boral Capital	Locked ➜ Locked	Locked	Nov 14 2024
D. Boral Capital	Locked ➜ Locked	Locked	Nov 12 2024

Analyst Rating	Date
Locked D. Boral Capital: Locked ➜ Locked	Mar 25 2025
Locked Oppenheimer: Locked ➜ Locked	Mar 24 2025
Locked D. Boral Capital: Locked ➜ Locked	Feb 05 2025
Locked D. Boral Capital: Locked ➜ Locked	Jan 02 2025
Locked Brookline Capital: Locked ➜ Locked	Dec 18 2024
Locked D. Boral Capital: Locked ➜ Locked	Nov 14 2024
Locked D. Boral Capital: Locked ➜ Locked	Nov 12 2024

Discover more stocks with a high price target

Novo Nordisk 85.76%

MongoDB 77.37%

TUI 71.12%

Coinbase Global, Inc. 63.83%

Infineon 61.01%

Alibaba Group Holding Ltd 55.02%

BioNTech SE - ADR 45.05%

Snowflake 42.40%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now